Attovia Therapeutics: Funding, Investors & Team (Oct 2026)
Attovia develops biotherapeutics aimed at treating immune-mediated diseases through its proprietary ATTOBODY technology. The company focuses on creating innovative therapies that target various immune responses, contributing to advancements in the biotechnology sector. Attovia is actively engaged in research and development, working on a pipeline of therapeutics designed to address unmet medical needs in immune disorders and oncology. Recent funding efforts support the progression of its clinical programs, highlighting its commitment to advancing healthcare solutions. By leveraging its unique technology, Attovia seeks to enhance treatment options for patients suffering from complex diseases.
Attovia Therapeutics has raised $195M across 2 funding rounds on record, the most recent a Series C of $90.0M announced in Apr 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Attovia Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Attovia Therapeutics Funding Rounds
Attovia Therapeutics raised $105M in a Series B announced in May 2024.
11 months later, a Series C of $90.0M was announced in Apr 2025.
Attovia Therapeutics Founders and Leadership Team
Contact details for the Attovia Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Attovia Therapeutics Funding Compared to Other Biotechnology Startups
Attovia Therapeutics' latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Attovia Therapeutics in Biotechnology and San Carlos
Companies Similar to Attovia Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Attovia Therapeutics Funding FAQs
What does Attovia Therapeutics do?
Attovia develops biotherapeutics aimed at treating immune-mediated diseases through its proprietary ATTOBODY technology. The company focuses on creating innovative therapies that target various immune responses, contributing to advancements in the biotechnology sector. Attovia is actively engaged in research and development, working on a pipeline of therapeutics designed to address unmet medical needs in immune disorders and oncology. Recent funding efforts support the progression of its clinical programs, highlighting its commitment to advancing healthcare solutions. By leveraging its unique technology, Attovia seeks to enhance treatment options for patients suffering from complex diseases.
How much funding has Attovia Therapeutics raised?
Attovia Therapeutics has raised $195M across 2 rounds on record. The most recent is a Series C of $90.0M announced in Apr 2025.
When did Attovia Therapeutics last raise funding?
Attovia Therapeutics' most recent funding round on record is a Series C of $90.0M, announced in Apr 2025.
Who founded Attovia Therapeutics?
FundedIQ lists Tao Fu (Founder) at Attovia Therapeutics.
Where is Attovia Therapeutics headquartered?
Attovia Therapeutics is based in San Carlos, California, United States.
How many employees does Attovia Therapeutics have?
Attovia Therapeutics is in the 11-50 employee band.
How does Attovia Therapeutics' funding compare to other Biotechnology startups?
Attovia Therapeutics' latest round of $90.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Attovia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Attovia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.